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rise in the level at birth, this rise is but slight. The 8th-day
level is likewise not appreciably affected.l, 3, 13 Consequently,
it is postulated that the birth and 8th-day values are largely
determined by some factor other than vitamin K, whereas
vitamin K is concerned to a large degree in the fall between
the 2nd and 5th days. It follows that an improvement in the
stillbirth rate in patients with normal labours and deliveries
cannot be expected as a result of the administration of vitamin
K.
The prothrombin level falls to an even greater extent
with prolonged labour, albuminuria, placental insufficiency,
and the administration of barbiturates during labour. The
infants in these cases also have an abnonnally low prothrom-
bin level at birth. Intrapartum vitamin K has been shown to
raise the low birth level and prevent the severe fall in the large
majority of these cases.l , 4 Thus the benefit to the neonate
from intrapartum maternal injection is superior to that
accruing from injection of the neonate.
Vitamin K given intra partum by intramuscular injection
is effective, after 15 minutes, in preventing the expected fall
in neonatal prothrombin level, but the mother requires a
repeat injection every 24 hours until delivery.4, 5 Bohlender,
however, claims to have achieved the same effect with injection
of vitamin K only 5 minutes before delivery.s
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The possibility that routine intrapartum administration of
vitamin K may produce a reduction in the incidence of
neonatal haemorrhage has been debated for many years, and
opinions remain divided. This state of uncertainty served as
a stimulus to the present study, in which an attempt was
made to evaluate the effects of intrapartum vitamin K among
African and Indian patients.
Haemorrhagic lesions in the newborn may be due to various
factors, viz. (1) Vascular lesions, traumatic or anoxic;
(2) low prothrombin levels, which may be the result of insuf-
ficiency of supply or inefficiency in fonnation, the latter
consideration being particularly important in the premature
baby; (3) coagulation factors other than prothrombin; and
(4) factors impairing capillary resistance. The prothrombin
level, therefore, is only one of several significant factors.
The average newborn baby has a birth prothrombin level
of 20-50% of the normal adult value. Thereafter there is a
fall till the 3rd day to approximately 10 %of the adult value,
and a subsequent rapid rise till the end of the 1st week.
The maximum fall in prothrombin level occurs between the
2nd and 5th days,l, ! and it has been shown that the intra-
partum maternal administration of vitamin K prevents this
fall. While the vitamin also produces a statistically significant
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By far the majority of patients at the King Edward VITI
Hospital are drawn from the low income group of Africans
and Indians, in whom the diet is invariably-and sometimes
grossly-deficient. .
Certain investigators have shown that there is a seasonal
variation in haemorrhagic lesions-being maximal in
spring.I, ; The generally accepted view at present is that
this is due to an alteration in capillary permeability.7 Our
series includes too few cases during autumn to evaluate this
factor fully but, on the figures available, comparatively few
haemorrhages occurred in midsummer, while the remainder
were scattered at random, with no particular peak in spring.
It is an interesting fact that artificial feeding as opposed to
breast feeding has been shown to result in only a very short
and slight fall in prothrombin level, of no more than 24
hours' duration.1 The babies in this series were almost
exclusively breast-fed or fed on expressed breast milk.
In Table II is shown the manner of birth expressed as a
percentage for each group, viz. those receiving vitamin K
TABLE IT. COMPARlSO OF MANl'-'ER OF BIRTH (% OF TOTAL IN EACH
GROUP)
This theoretical basis underlies the rationale of intrapartum
administration of vitamin K. A large number of investigations
on this basis have produced entirely contradictory results.
For example, the largest reported series are those of Dam et
aP in Scandinavia, with 33,000 cases, and Potter; in America,
with 13,000 cases. Potter found no improvement with
vitamin K admirustration. Dam, on the other hand, who
investigated prothrombin time changes in great detail, came
to the conclusion that intrapartum vitamin K lowered the
number of neonatal deaths from haemorrhagic lesions. It is
generally accepted, however, that the improvement is too
slight to warrant the routine use of vitamin K.
In view of the fact that African and Indian patients differ
markedly from the average European in the degree of mal-
nutrition, liver damage, frequency of childbearing, and
traumatic factors during labour, it was decided to investigate
the position in this group of patients at the King Edward VIII
Hospital, Durban.
A further reason for the investigation was our observation
that, as shown by the figures here reported, the incidence of
fatal haemorrhagic lesions among European babies as quoted
by most authorities is less than O· 5 %, whereas there is a




Vitamin K (tetrasodium 2-methyl-l, 4-naphthohydro-
quinone diphosphoric acid ester*), given intramuscularly in
the dosage of 10 mg., was used throughout the series. It
was administered by the nursing staff in the admission room
of the labour theatres Oabour 'wards'), as far as possible to
alternate patients upon arrival. The majority received the
vitamin K between} hour and 4 hours before delivery, a
slightly smaller number between 4 and 12 hours, and very
few more than 24 hours before delivery.
A total of 7,802 cases was investigated between May 1957
and March 1958. Patients delivering before admission,
those with stillbirths and those with babies weighing less
than 1,000 g. (2 lb. 2t oz.) were excluded from the series.
Comparison o/Groups
In Table I is shown the number in each group expressed as
a percentage of the total (7,802) and classified according to
parity and maturity. The groups are seen to be proportionally
TABLE I. TOTAL CONSECUITVE VIABLE LIVEBIRTHS IN HOSPtTAL (7,802)
Received Vir. K No Vir. K
(3,312) (4,490)
{
Premature }. 3% (02) 1· 8% (143)
Mature 10'4% (814) 12'4% (966)
{
Premature 2'3% (180) 4'5% (357)
Mature 28'4% (2,216) 38'7% (3,024)
comparable, with the exception of the multiparous premature
group, where there is overloading of those who did not
receive vitamin K. For this reason, and because maturity
is shown to be an important factor in the incidence ofhaemor-
rhagic lesions, the premature and mature groups are con-
sidered separately in the final evaluation.
In assessing a series of this nature, various other factors
should be comparable, such as diet, season and manner of
birth.
* Synkavit (Roche).
Vertex fPremature 76·9 (216) 81·9 (410)"LMature 89·9 (2,726) 87·3 (3,484)
Breech {premature 14·1 (40) 9·2 (46)Mature 1·7 (52) 2·3 (92)
Forceps fPremature 2·1 (6) 2·6 (13)"LMature 3·0 (92) 3·6 (144)
Caesarean fPremature 7 ·1 (20) 5·8 (29)
section "LMature 4·2 (128) 5·7 (229)
Symphysiotomy fPremature 0·0 (0) 0·4 (2)"LMature 1·0 \32) }·o (41)
and those not receiving vitamin K, with separate consider-
ation of premature and mature babies. It is evident that these
groups are comparable apart from a small disproportion
among the premature breech deliveries in favour of those
who did not receive the vitamin.
In the foregoing tables it is clear that the two groups-
those who received vitamin K and those who did not-
are comparable, with the exception of the number of multi-
parous premature infants.
In Table III is shown the distribution of the neonatal
deaths according to the manner of delivery, grouping the
TABLE m. D15TRlBUTlON OF NEONATAL DEATHS (% OF TOTAL IN
EACH. GROUP)
Received Vit. K No Vit. K
Vertex fPremature 9·9 (28) 12·8 (64)"LMature 6'5 (15) 0·85 (34)
Breech fPremature 2·5 (7) 2·4 (12)"LMature (f03 (1) 0·05 (2)
Forceps fPremature 0·3 (I) 0·4 (2)"LMature 0·29 (9) 0·20 (8)
Caesarean . fPremature 0·3 (I) 1·4 (7)
section "LMature. - 0·03 (1) .0·13 (5)
. .' fPreinature 0·0 (0) 0·2 (1)
SyrnI?hy.slot0!:O).:. t Mature.. 0·09 (3) 0·15 (6)














TABLE VI. INFLUENCE OF VITAMIN K UPON THE I 'CIDE. 'CE OF





TABLE V. I lFLUENCE OF VITAMIN K UPON THE tNCIDE 'CE OF





_ TO vitamin K
Received vitamin K
Received vitamin K
No vitamin K 36
P=<·1
enough, but when subjected to statistical analysis, the
numbers are insufficiently large to render them statistically
significant. Their significance is possibly further dwarfed
by the decision to administer vitamin K to a number of
suspect neonates after delivery. As the intrapartum adminis-
tration of vitamin K shows a resultant trend towards reduction
in fatal neonatal haemorrhages, and further support stems
from clinical impressions which prompted the undertaking
of this investigation, it would seem unjustified to withhold
its administration.
Haemorrhagic Lesions in the Mature Group
In the mature group it is again seen that the death rate is
halved in those who received vitamin K (Table VI). These
figures are statistically significant. As was seen above, the
greatest disparity exists in the number of multiple-site
haemorrhages-in some cases unassociated with intracranial
haemorrhage-of which some were true haemorrhagic disease
of the newborn.
There is a steep rise in death rate among those babies
whose mothers received vitamin K more than 24 hours
before delivery, presumably due to the increased hazards of
prolonged labour, and perhaps also due in part to the falling
efficacy of vitamin K. To achieve the optimum effect of
vitamin K, patients should receive a repeat dose within 24
hours.
Complications of Vitamin-K Administration
Several investigators have reported a relationship between
high doses of vitamin K and kernicterus.9 Bound and Telfer,lo
for instance, in a series of 55 premature infants receiving
10 mg. on 3 successive days, report an average serum-
bilirubin level of 15·4 mg. %; 38 %of their infants had serum-
bilirubin levels above their kernicterus level of 18 mg. and
2 died of kernicterus.lo This result is borne out by Laurance, 11
and Meyer and Angus.u
In our series of cases, there were no deaths from kernicterus,
though one baby developed the condition and subsequently
recovered. Vitamin K had not been administered in this
particular case. In this series, therefore, the dose administered
did not have an adverse effect on the babies, though it may be
higher than is necessary. It has been proved that a dosage
of 2 I-'g. to the babies at birth is sufficient to prevent the
2nd to 5th day fall in prothrombin leveJ.l
Intracranial {premature 17·7 (5) 50·0 (25)
haemorrhage Mature 3·9 (12) 4·8 (19)
Other {Premature 10·6 (3) 12·0 (6)
haemorrhage Mature 0·33 (1) 1·8 (7)
Other causes {Premature 95·7 (27) 100·0 (50)
Mature 5·3 (16) 5·0 (20)
--
Total deaths {premature 131·2 (37) 172·0 (86)
Mature 9·6 (29) 13·8 (55)
Total neonatal deaths, 207. Postmortems performed, 86· 5%
(179).
that there is virtually no difference in death rate from causes
other than haemorrhagic lesions. The large majority of
these cases were babies dying of asphyxia neonatorum.
The difference in total death rate, therefore, is due to the
haemorrhagic group, both in premature and mature infants.
The expected neonatal death rate as quoted in the literature
is 19-20 per thousand.8 In the total series here reviewed it is
26· 5 per thousand.
TABLE IV. COMPARISON OF THE EFFECT OF VITAMIN K UPON THE
AETIOLOGY OF 207 NEONATAL DEATHS (RATE PER THOUSAND)
Aetiology Received Vit. K No Vit. K
Multiple site {premature 7·09 (2) 10·0 (5)
haemorrhage Mature O' 0 (0) 2· 3 (9)
cases in the same manner as in Table ll. There were 207
neonatal deaths, 123 premature and 84 mature. Of these,
intrapartum vitamin K had been administered in 66 and no
vitamin K given in 141.
Aetiology ofNeonatal Deaths
Table IV shows the effects of vitamin K on neonatal
deaths of varying aetiology. It will be seen from the figures
Haemorrhagic Lesions in the Premature Group
Considering the haemorrhagic lesions as a whole in pre-
mature infants, it is clearly shown that a much higher per-
centage died ofhaemorrhage than in the mature group.
Although a large number died of intracranial haemorrhage,
in many cases there was no sign of tentorial tears, and
haemorrhage occurred into the pons, ventricles, subarachnoid
space and medulla, and in a very few extended down the cord.
These cases usually had a moderate to marked degree of
atelectasis. Haemorrhage was even found occurring into the
pericardial sac. These findings suggest that the initial vascular
lesion in a large number was anoxic rather than traumatic.
In fact, in both premature and mature babies one feels that the
words 'birth trauma' slip too glibly off the tongue without
sufficient account being taken of other important factors.
The difference in average weights of the babies in the group
which received vitamin K and that which did not is negligible,
being 3 lb. 9 oz. in those who received it, and 3 lb. 11 oz. in
those who did not.
As can be seen in Table V, the calculated death rate per
thousand is halved in that group in which intrapartum
vitamin K was given. These figures may look impressive
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CONCLUSION
The results of this investigation permit the statement that
routine intrapartum administration of vitamin K has thera-
peutic value in the prevention of fatal haemorrhagic lesions
in newborn African and Indian babies.
SUMMARY
1. Fatal haemorrhagic lesions in the African and Indian
neonate' occur frequently-apparently more frequently than
in Europeans.
2. In mature babies, it is clear from our figures that a
significant reduction in these haemorrhagic lesions occurs
when routine intrapartum vitamin K is given.
3. In premature babies, there is a similar trend-although
our figures are insufficient to be statistically significant.
4. Routine intrapartum administration of vitamin K has
therapeutic value in the prevention of fatal haemorrhagic
lesions in newborn African and Indian babies.
OPSOMMING
Hier word 'n ondersoek beskryf wat in King Edward VllI-
Hospitaal onderneem is om te probeer vasstel hoe waardevol
die toediening van vitamine K is gedurende kraam om dode-
like bloedings by Naturelle- en Indier-pasgeborenes te voor-
kom.
Wat voltydse babas betref, toon ons syfers aan dat daar
bepaald 'n betekenisvolle vermindering is van bloedende
letsels wanneer vitamine K as roetine gedurende kraam toe-
gedien word.
In die geval van vroeggebore babas is daar 'n soortgelyke
strekking.
Wat Naturelle- en Indierpasiente betref, dui die getuienis
dus aan dat die roetine-toediening van vitamine K gedurende
kraam bepaalde terapeutiese waarde het by die voorkoming
van dodelike bloedende letsels by pasgeborenes.
J should like to thank Prof. Derk Crichton for his encourage-
ment and helpful advice; Dr. S. Disler, Medical Superintendent,
for permission to publish the figures; members of the Pathology
Department, particularly Dr. S. S. Grove, who performed the
postmortem examinations and made their reports available; and
Dr. L. Goldman and other members of the Division of Obstetrics
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SOUTH AFRICAN MEDICAL AND DENTAL COUNCIL: SUID-AFRIKAANSE GENEESKlThi'DIGE
K - TA..NDHEELKUl\1])IGE RAAD
The 70th meeting of the South African Medical and Dental
Council was held in the Board Room, Deal's Hotel, East London,
C.P., on 23-26 September 1959. The proceedings occupied 8
half-day sessions. Thirty members were present, including the
President (Prof. S. F. Oosthuizen) in the chair, the Vice-president
(Prof. H. W. Snyman), and the Treasurer (Or. R. V. Bird), together
with the .Registrar (Mr. W. H. Barnard).
PRESIDENT'S OP£IoHNG REMARKS
After speaking in suitable terms of the death of Dr. J. N. W.
Loubser, a member of the Council until last year, the President
referred to the great amount of work accomplished by members
of the various committees between meetings of the Council. A
favourable atmosphere for the Council's work resulted from the
good relations that were maintained with the Department of
Health, the Uuiversities, other statutory bodies such as the Nursing
Council and the Pharmacy Board, professional bodies such as the
Medical and Dental Associations, and the different voluntary aid
organizations.
The Council, Prof. Oosthuizen said, had to deal mainly with 3
categories of problems, viz. (a) those that clearly fall within its
purview, (b) those that do not, and (c) those about which there i~
some doubt and difference of opinion. He dealt briefly \vith the
following matters in the first category:
1. Artificial human insemination. The Minister of Health has
informed us that he is not proposing to appoint a Commission,
but that he welcomes the Council's offer to obtain information
for him. The Council is now cooperating with the Secretary for
Health on the matter.
2. Amendment of section 34 (illegal practice of medicine).
FoIlmving representations from the Council, the Minister has
asked for a memorandum. This J am drafting, but its completion
must await the advice and comments of the Medical and Dental
Associations and other bodies. Amongst other information, we
have received from an eminent Cape Town surgeon a fine report
complete with case histories.
3. Proposed amendment of the Act to validate rule 6 (informal
proceedings on receipt of complaints of unethical conduct). There
are many senior members who \vish the Council to have the
specific power to deal with certain types of complaint by procedures
short of a full enquiry. The question was recently raised again in an
interview I had \vith the Attorney General of the Transvaal. The
Executive Committee is reporting on it to the Council.
4. Rule 19 (advertising of professional appointments). The
Executive Committee has carried out the Council's instructions,
including an interview with the Medical Association, and is
reporting on the subject at this meeting.
5. Registration ofspecialists and condirions ofpractice. This very
important matter has been brought to finality by the ad hoc
Committee, whose recommendations are before this meeting.
6. Registration ofoptometrists. After many years of negotiation,
good progress towards a compromise was made at a recent meeting
with representatives of the Medical Association and the South
African Optical Association. The Federal Council of the Medical
Association has the matter under consideration. A report is before
this meeting. .
7. Registration of doctors from abroad. At its last meeting the
Council agreed to certain principles contained in my report. The
Executive Committee has now drafted the necessary amendments
to the Act and regulations and these will be before this meeting
for submission to the Minister.
8. Proposed Council building. After considerable investigation
and discussion, the ad hoc Committee recommends the Council
not to proceed \vith the erection of its own building at this stage.
9. Medical technologists. A conference of interested persons was
recently held and recommendations are made to the Council
about the proposed training of this class of auxiliaries. The
training will be brought in line With the pattern of the Civil Service
Commission.
10. Disciplinary matters. The Council's committees have dealt
with a number of disciplinary cases, and I am glad to announce
that the findings in all the cases have been accepted without any
application to the Supreme Court for a review.
11. Diverse. (a) The finances of the Council are sound and its
work has not suffered through lack of funds. (b) There is a steady
